ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
82.765
0.00%
US Dollar vs AUD
1.514
-0.05%
Bitcoin
63,516.00
1.00%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. KV Pharmaceutical Co. CL A (KV.A)

  7. KV Pharmaceutical Co. CL A (KV.A) News

KV.A

K V Pharma (KV.A)

KV Pharmaceutical Co. CL A
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:KV.A
DateTimeSourceHeadlineSymbolCompany
17/09/201300:26PR Newswire (US)KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million RecapitalizationNYSE:KV.AKV Pharmaceutical Co. CL A
25/01/201300:00PR Newswire (US)Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%...NYSE:KV.AKV Pharmaceutical Co. CL A
29/12/201204:43PR Newswire (US)K-V Pharmaceutical Receives Court Approval of Hologic SettlementNYSE:KV.AKV Pharmaceutical Co. CL A
13/12/201210:39PR Newswire (US)K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of P...NYSE:KV.AKV Pharmaceutical Co. CL A
10/08/201222:00PR Newswire (US)K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy CourtNYSE:KV.AKV Pharmaceutical Co. CL A
09/08/201201:09PR Newswire (US)K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy CourtNYSE:KV.AKV Pharmaceutical Co. CL A
08/08/201202:16PR Newswire (US)K-V Pharmaceutical Class A and Class B Common Stock Begin Trading on the OTC MarketsNYSE:KV.AKV Pharmaceutical Co. CL A
06/08/201221:57PR Newswire (US)K-V Pharmaceutical Announces Planned Transition of Trading of Class A and Class B Common Shares to the OTC MarketsNYSE:KV.AKV Pharmaceutical Co. CL A
04/08/201214:56PR Newswire (US)K-V Pharmaceutical Company Files Voluntary Petitions for Reorganization to Restructure Financial ObligationsNYSE:KV.AKV Pharmaceutical Co. CL A
04/08/201201:27Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NYSE:KV.AKV Pharmaceutical Co. CL A
01/08/201207:09Edgar (US Regulatory)Securities Registration Statement (S-1)NYSE:KV.AKV Pharmaceutical Co. CL A
27/07/201206:27Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NYSE:KV.AKV Pharmaceutical Co. CL A
21/07/201206:05PR Newswire (US)K-V Pharmaceutical Company Announces Additional Notification from NYSE Regarding Listing CriteriaNYSE:KV.AKV Pharmaceutical Co. CL A
14/07/201206:43Edgar (US Regulatory)Amended Current report filing (8-K/A)NYSE:KV.AKV Pharmaceutical Co. CL A
07/07/201206:21Edgar (US Regulatory)Current report filing (8-K)NYSE:KV.AKV Pharmaceutical Co. CL A
04/07/201205:35Edgar (US Regulatory)Current report filing (8-K)NYSE:KV.AKV Pharmaceutical Co. CL A
02/07/201223:15PR Newswire (US)FDA Issues Further Guidance About Makena®NYSE:KV.AKV Pharmaceutical Co. CL A
30/06/201208:51PR Newswire (US)K-V Pharmaceutical Company Announces Notification from NYSE Regarding Listing CriteriaNYSE:KV.AKV Pharmaceutical Co. CL A
23/06/201206:32Edgar (US Regulatory)Current report filing (8-K)NYSE:KV.AKV Pharmaceutical Co. CL A
21/06/201206:19Edgar (US Regulatory)Current report filing (8-K)NYSE:KV.AKV Pharmaceutical Co. CL A
19/06/201206:36Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)NYSE:KV.AKV Pharmaceutical Co. CL A
18/06/201223:14PR Newswire (US)FDA and CMS Issue Important Updates on Makena®NYSE:KV.AKV Pharmaceutical Co. CL A
08/06/201207:12Edgar (US Regulatory)Current report filing (8-K)NYSE:KV.AKV Pharmaceutical Co. CL A
26/05/201206:15PR Newswire (US)K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual Market ActivityNYSE:KV.AKV Pharmaceutical Co. CL A
17/05/201207:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:KV.AKV Pharmaceutical Co. CL A
17/05/201207:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:KV.AKV Pharmaceutical Co. CL A
17/05/201205:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:KV.AKV Pharmaceutical Co. CL A
17/05/201205:45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:KV.AKV Pharmaceutical Co. CL A
17/05/201205:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:KV.AKV Pharmaceutical Co. CL A
17/05/201205:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:KV.AKV Pharmaceutical Co. CL A
 Showing the most relevant articles for your search:NYSE:KV.A

Your Recent History

ASX
XAO
Australian SE All Ordina...
FX
GBPAUD
Sterling vs AUD
NASDAQ
TSLA
Tesla
NASDAQ
NVDA
NVIDIA
NYSE
JPM
JP Morgan Chase
ASX
XMM
S&P ASX 300 Metals and M...
FTSE
UKX
FTSE 100
NYSE
KO
Coca Cola
NYSE
MCD
McDonalds
PM
XAUUSD
Gold vs US Dollar
ASX
AMP
AMP
CCOM
SILVER
SILVER
ASX
WPL
Woodside Petroleum
ASX
XTO
S&P ASX 100
NYSE
MRK
Merck
ASX
TLS
Telstra
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved